Scientists from Pennington Biomedical Research Center, together with a colleague from Peking University People’s Hospital in China, led a special collection and published an editorial in Frontiers in endocrinologyhighlighting the transformative role that digital health technologies play in the management and prevention of diabetes.
The editorial highlights studies that highlight how innovations in digital technology are enabling better self-management, personalized treatments and seamless communication between patients and healthcare providers. The main article was written by Dr. Gang Hu and Dr. Yun Shen of Pennington Biomedical and Dr. Xiantong Zou from Beijing. University.
“Digital tools offer unprecedented opportunities to improve patient outcomes through better monitoring, individualized care and more efficient communication between patients and healthcare providers,‘, the authors wrote.
Digital health tools promise to make diabetes care more accessible, effective and adaptable to patients’ individual needs. Advances in wearable devices, mobile applications and telemedicine can support patient self-management, personalize treatment and improve health outcomes. The editorial addresses key challenges with these technologies, including data privacy and accessibility, and encourages continued research and development in this promising area.
“As the field continues to evolve, digital healthcare innovations are poised to play an increasingly critical role in the prevention and management of diabetes, paving the way for more efficient and equitable healthcare.the authors concluded.
Dr. Hu is professor and director of the Chronic Disease Epidemiology Laboratory, and Dr. Shen is an assistant professor of research in chronic disease epidemiology at Pennington Biomedical. Dr. Zou is an attending physician and associate professor at Beijing University People’s Hospital.
This editorial provides insight into the crucial role that digital technologies play in our daily lives, and especially how these technologies can be used in disease management and treatments. The work done by Dr. Shen and Dr. Hu here at Pennington Biomedical, in collaboration with colleagues around the world, demonstrates Pennington Biomedical’s collaborative mindset and the commitment we have to advancing healthcare through innovative research.”
Dr. John Kirwan, executive director of Pennington Biomedical
Source:
Magazine reference:
Shen, Y., et al. (2024). Editorial: Digital technology in the treatment and prevention of diabetes. Frontiers in endocrinology. doi.org/10.3389/fendo.2024.1511236.